+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 1 Actively Recruiting clinical trials

E

Actively Recruiting

Researchers are investigating new ways to diagnose tuberculosis TB in children in Bolivia, particularly addressing challenges in detecting TB in young children due to limited accuracy and availability of current tests. The study focuses on a novel CRISPR-mediated blood test CRISPR-TB that detects TB DNA fragments in the blood, aiming to improve detection especially in children with confirmed, unconfirmed, or unlikely TB. The research also explores combining blood test results with lung imaging techniques analyzed by artificial intelligence to enhance TB diagnosis. The study will enroll children aged 2 months to 14 years who are suspected of having TB based on respiratory symptoms and Bolivian health guidelines. Participants include those with confirmed TB, unconfirmed TB, unlikely TB, and well children without symptoms. The study involves multiple diagnostic tests, including blood tests, chest X-rays, lung ultrasounds, and specimen collections like sputum or gastric aspirate for culture and PCR analysis. Imaging data will be analyzed using advanced machine learning tools to correlate with blood test results. Participants will undergo initial evaluations before any TB treatment, including clinical exams, blood and respiratory sample collections, and imaging. Children diagnosed with TB will have follow-up assessments at 1 week, 2 weeks, and 2 months during treatment to monitor disease markers and response. Well children controls will have a single evaluation. The main outcome measured is the level of TB DNA in the blood at baseline and after treatment, along with imaging scores. The study aims to validate these diagnostic tools to better detect pediatric TB in resource-limited settings, with participation expected to last up to two months for treated children.

Age: 2Months - 14YearsAll Genders
1 location